Our new kit that detects SARS-CoV-2, influenza A&B, RSV A&B in single mix is on the market.
Bosphore Novel Coronavirus (2019-nCoV) Detection Kits continue to play an active role in preventing the epidemic by been used in diagnosis more than 4 millions of people in more than 50 countries.
A new member of the coronavirus-related product group developed by our R&D team, Bosphore SARS-CoV-2 / Flu / RSV Panel Kit detects 5 virus types in a single mix.
The role of the kit is crucial in the rapid and correct diagnosis of respiratory pathogens, which are the most common in the winter months, thus providing effective treatment.
The internal control of our new kit is based on the detection of human endogenous nucleic acid sequence (RNase P) present in human genome has been employed in order to check extraction, PCR inhibition and sampling or application errors.